Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.
about
P1343
Exposure to Music Alters Cell Viability and Cell Motility of Human Nonauditory Cells in Culture.ABCB1 regulation through LRPPRC is influenced by the methylation status of the GC -100 box in its promoter.Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.Knocking down low molecular weight protein tyrosine phosphatase (LMW-PTP) reverts chemoresistance through inactivation of Src and Bcr-Abl proteins.Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia.Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line.Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance.Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?Ultrasound-assisted Extraction of Ursolic Acid from the Flowers of Ixora coccinia Linn (Rubiaceae) and Antiproliferative Activity of Ursolic Acid and Synthesized Derivatives.OCT4 mutations in human erythroleukemic cells: implications for multiple drug resistance (MDR) phenotype.Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients.3β-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression.Hedgehog signaling maintains chemoresistance in myeloid leukemic cells.LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells.p53 flow cytometry evaluation in leukemias: correlation to factors affecting clinical outcome.Comparison of the cytotoxic effect of lapachol, alpha-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells.The husk fiber of Cocos nucifera L. (Palmae) is a source of anti-neoplastic activity.Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile.Vanadate-induced cell death is dissociated from H2O2 generation.Effect of extracellular ATP on the human leukaemic cell line K562 and its multidrug counterpart.Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: a possible use in chemotherapy.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system.Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.Functional Characterization of ABCC Proteins from Trypanosoma cruzi and Their Involvement with Thiol Transport.Metabolic Reprogramming During Multidrug Resistance in Leukemias.Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer.
P2860
Q30378027-10928B28-92FC-4783-9060-DA8FC2FF1C29Q34183433-BE7269F8-19B4-416C-A20C-43F0165F5C7FQ34348134-1579EECF-7A09-4E9E-A6F1-D97FC75125B5Q34408095-F9E3BEC8-5857-4019-B64A-AD64415CCE67Q34650656-866C93A7-8875-44CE-8AC1-27C8AAA433C5Q35051303-B9A786F8-B26D-4344-A4B2-DB7C4F2F148EQ35991845-F5D26FEC-2607-41D6-89EC-45D0DC6FD125Q37148845-E26D1683-C6F8-4BB8-9406-340E82E12112Q38144200-35CD7A31-E6BB-41AB-85D2-9BF87DB232CAQ38702357-57BB69D2-8B8D-41E3-A8A4-C954C8E1FF16Q38944007-741DD06A-EDCF-4886-BCBC-73DEC36AF4A2Q39121828-26E95FF2-A45C-4252-81A2-B217FC91F01FQ39404062-C9330B84-74A1-432F-8B01-CA9CF1397F02Q39552767-397B0CA0-8AEF-4BC1-984A-6C7E3059D479Q39660008-444C6FC8-E046-4EB3-B64F-78A32625F72CQ39662047-CCCBB422-E995-4382-B1CF-07D7907C5D0CQ39700748-E6464789-E194-449D-9C12-46CE8A86AE0BQ39732888-681C6BD3-F98A-4D1B-8DCE-22E55ADA24B0Q39877795-BFD75494-58A5-437D-A7FF-8F6C260B69A2Q40090742-1AED7E7F-92AD-4E1E-92FD-9FAAFAD0F0F1Q40129152-B0734E2C-5A7E-4551-960F-5837A3271F70Q40141443-130D765F-809F-44D0-827B-2D54D15BFCB0Q40258468-10D57BBC-4031-4FE4-9E3D-977A907B7BF0Q46625055-9BE2A95D-1548-4643-8508-B70DD8A049D3Q47216949-CBC3A812-2329-4AFE-A86D-4B3FEC7DC9D8Q48206395-894F8F81-D45C-4A55-AFE8-F3960EDA440AQ48306335-DE0D99E9-5E42-4814-9284-EE340DDD625EQ50318718-CF5830B0-B1D9-4E32-805D-6B2FE70B3951Q52575780-F5D4EE1F-E107-4C84-932B-8C9D88060A43Q53886209-0279DF35-DEA4-4591-A133-BA1721679B75Q55006981-009C9D7F-31E7-46D0-A0D9-2293C4B47776
P2860
Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@ast
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@en
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@nl
type
label
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@ast
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@en
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@nl
prefLabel
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@ast
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@en
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@nl
P2093
P2860
P1476
Multidrug resistance in tumour ...... stant cell line K562-Lucena 1.
@en
P2093
Capella MA
Marques-Santos LF
Rumjanek VM
Trindade GS
Wagner-Souza K
de-Oliveira MC
P2860
P356
10.1590/S0001-37652001000100007
P4510
P577
2001-03-01T00:00:00Z